AT
AN2 Therapeutics Inc
🇺🇸XNAS.ANTXUnited StatesHealthcare
$5.36USDdown -0.11 (-2.01%)OpenDelayed1:38 PM
Price$5.36-0.11 (-2.01%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0373261058
- CUSIP
- 37326105
Company
- Employees
- 21
- Headquarters
- Menlo Park, United States
- CEO
- Mr. Eric E. Easom
Market
- Shares outstanding
- 37.7M
- Market cap
- $202.27M
Highlights
- Market cap
- $202.27M
- EPS LTM
- -$0.96calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.58calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$36.28M+2.95%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$30.68M+13.58%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.